The Current Ratio as of November 2024 (TTM) for Cytosorbents Corporation (CTSO) is 1.97K

According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.97K. This represents a change of 298.91% compared to the average of 493.55 of the last 4 quarters.

Cytosorbents Corporation (CTSO) Historical Current Ratio (quarterly & annually)

How has CTSO Current Ratio performed in the past?

The mean historical Current Ratio of Cytosorbents Corporation over the last ten years is 3.33. The current 1.97K Current Ratio has changed 5.90% with respect to the historical average. Over the past ten years (40 quarters), CTSO's Current Ratio was at its highest in in the September 2024 quarter at 1.97K. The Current Ratio was at its lowest in in the March 2017 quarter at 1.02.

Cytosorbents Corporation (CTSO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cytosorbents Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cytosorbents Corporation (CTSO) Average Current Ratio

How has CTSO Current Ratio performed in the past?

The current Current Ratio of Cytosorbents Corporation (CTSO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cytosorbents Corporation (CTSO) Current Ratio vs. Peers

How is CTSO’s Current Ratio compared to its peers?

Cytosorbents Corporation’s Current Ratio is greater than ProSomnus, Inc. Common Stock (0.30), greater than LivaNova PLC (3.37), greater than Electromed, Inc. (5.53), greater than OrthoPediatrics Corp. (7.17), greater than Surmodics, Inc. (3.96), greater than NeuroPace, Inc. (5.59), greater than ClearPoint Neuro, Inc. (4.54), greater than TELA Bio, Inc. (2.62), greater than CVRx, Inc. (11.32), greater than Orthofix Medical Inc. (2.39), greater than Artivion, Inc. (1.88), greater than Heska Corporation (6.70), greater than Paragon 28, Inc. (3.50), greater than Inogen, Inc. (2.66), greater than Pulmonx Corporation (7.70), greater than Apyx Medical Corporation (5.46),

Build a custom stock screener for Cytosorbents Corporation (CTSO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytosorbents Corporation (CTSO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.